Our Pipeline.

Our pipeline includes a diverse portfolio of research programs and therapeutic areas, each designed to tackle specific diseases and conditions.

Dive Into the many applications of our ACeRT Technology.

Neurodegenerative Disorders

Applying Athergen’s Cell Reprogramming Technology in neurodegenerative disorders offers several advantages, providing a source of healthy, functional cells to replace those damaged or lost due to disease. Second, because the reprogrammed cells are induced in vivo, or derived from the patient, they are less likely to be rejected by the immune system, reducing the risk of complications associated with transplantation. Finally, this approach can be tailored to individual patients, accounting for differences in genetics and disease progression, which may lead to more effective treatments. Cellular reprogramming may soon become a powerful tool in the fight against neurodegenerative disorders, offering new hope for patients and their families.

Alzheimer’s disease
Parkinson’s disease
Multiple sclerosis
ALS (Amyotrophic Lateral Sclerosis)

Metabolic Disorders

The application of Athergen’s cell reprogramming technology in metabolic disorders can help to restore normal metabolic processes, improving overall health and potentially reducing the need for long-term medications. Because the reprogrammed cells are induced in vivo, or derived from the patient, they are less likely to be rejected by the immune system, reducing the risk of complications associated with transplantation.

Diabetes (Type 1 and 2)
Obesity
Age-Related Macular Degeneration
Cellular Aging Reversal

Cardiovascular Diseases

Applying Athergen’s Cell Reprogramming Technology in cardiovascular conditions offers several key benefits, providing a source of healthy, functional cells to replace damaged or lost cells in the heart and blood vessels. This can improve the heart's overall function and potentially reverse some of the damage caused by the disease. Because the reprogrammed cells are induced in vivo, or derived from the patient, they are less likely to be rejected by the immune system, reducing the risk of complications associated with transplantation. This personalized approach can be adapted to individual patients, accounting for differences in genetics and disease progression, which may lead to more effective and targeted treatments.

Heart Failure
Myocardial Infarction

Retinal Disorders

Athergen’s Cell Reprogramming Technology in retinal disorders can potentially reverse some of the damage caused by different conditions of the eye associated with aging, leading to more effective and targeted treatments for several diseases.

Age-Related Macular Degeneration (“AMD”)
Diabetic Retinopathy
Glaucoma